CoaGlio IV trial: randomized, controlled, triple-blind, multinational phase III study of adjuvant prophylactic anticoagulation in patients with glioblastoma WHO IV - Kuhn, S A; Marosi, C; Pabinger, I (J Clin Oncol, 2015)
, et al.